Concept Life Sciences, a leading contract research organisation (CRO) specialising in integrated drug discovery, development and analytical services, has appointed Dr Adrijana Vinter as Chief Executive Officer.
Dr Vinter brings more than 20 years of experience spanning medicinal chemistry research, commercial development and executive leadership in the pharmaceutical and contract research industry sectors.
She has a track record of growing and scaling research services businesses, building international client relationships and leading international, multidisciplinary scientific teams.
Most recently, Dr Vinter served as Global Head of Drug Discovery and a member of the management board at Selvita, with full responsibility for a drug discovery business generating approximately €50 million in revenue and employing more than 400 people across Europe and the US.
Her remit included the scientific and strategic development of integrated discovery services, bringing together chemistry, biology, DMPK, bioinformatics and translational research to support high-quality programmes across global biotech and pharmaceutical clients. Here she also supported the introduction of advanced discovery platforms, including AI-supported discovery, spatial omics and translational models.
Previously, Dr Vinter held Chief Executive Officer and Chief Commercial Officer roles at Fidelta, becoming CEO in 2016. She built its international client base across US and European markets, delivered significant year-on-year revenue growth and led the expansion of its infrastructure, including its laboratory facilities. She also played a key role in Fidelta’s acquisition by Selvita in 2021.
